$16.49
-0.12%Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. Its Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer. The company's Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services. Its Concentra segment operates and provides occupational health centers and contract services at employer worksites that deliver occupational medicine, consumer health, physical therapy, and wellness services. As of December 31, 2021, the company operated 104 critical illness recovery hospitals in 28 states; 30 rehabilitation hospitals in 12 states; 1,881 outpatient rehabilitation clinics in 38 states and the District of Columbia; and 518 occupational health centers in 41 states, and 134 onsite clinics at employer worksites states. Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.
Thin margins leave little room for error. Cost management and pricing strategy are critical.
Acceptable margins but limited operational leverage. Operating expense control is important.
Minimal profitability after all expenses. Limited financial flexibility for reinvestment or shareholder returns.
Moderate tax rate typical for most corporations. Represents standard tax burden on profits.
Efficient profit conversion: Minimal margin compression from gross to net indicates lean operations and favorable tax/interest environment.
SEM โข NYSE
| Select Medical Holdings Corporation Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | Dec 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||||||||||
5.5B | 5.2B | 6.7B | 6.3B | 6.2B | 5.5B | 5.5B | 5.1B | 4.4B | 4.3B | 3.7B | 3.1B | 3B | 2.9B | 2.8B | 2.4B | 2.2B | 2.2B | 2B | 1.9B | |
GROSS PROFIT | ||||||||||||||||||||
(4.8B) | (4.6B) | (5.7B) | (5.6B) | (5.3B) | (4.7B) | (4.6B) | (4.3B) | (3.7B) | (3.7B) | (3.2B) | (2.6B) | (2.5B) | (2.4B) | (2.3B) | (2B) | (1.8B) | (1.8B) | (1.7B) | (1.5B) | |
629.3M | 633.6M | 932M | 733.4M | 919.4M | 821.3M | 812.9M | 740.2M | 709.4M | 621.2M | 531.2M | 482.7M | 480.2M | 505.4M | 495.9M | 408.1M | 420.1M | 361.5M | 331.6M | 366.9M | |
OPERATING INCOME | ||||||||||||||||||||
(294.7M) | (365.3M) | (377.2M) | (330.1M) | (205.6M) | (253.7M) | (341M) | (322.9M) | (274.1M) | (252.2M) | (197M) | (153.6M) | (141.3M) | (129.5M) | (185.2M) | (172M) | (184.3M) | (165.1M) | (137.7M) | (109M) | |
(154.4M) | (225.9M) | (170.2M) | (153M) | (147M) | (138M) | (128.5M) | (121.3M) | (114M) | (106.9M) | (92.1M) | (85.2M) | (76.9M) | (66.2M) | (62.4M) | (62.1M) | (113.3M) | (93.3M) | (80.4M) | (62.3M) | |
334.6M | 268.3M | 554.9M | 403.3M | 713.8M | 567.7M | 471.9M | 417.3M | 355.9M | 299.8M | 274.8M | 284.5M | 301.4M | 336.9M | 310.7M | 236.1M | 235.8M | 196.4M | 193.9M | 257.9M | |
PRE-TAX INCOME | ||||||||||||||||||||
(117.6M) | (128.6M) | (198.6M) | (169.1M) | (136M) | (153M) | (200.6M) | (198.5M) | (154.7M) | (170.1M) | (112.8M) | (85.4M) | (87.4M) | (95M) | (99.2M) | (112.3M) | (132.5M) | (145.9M) | (140.2M) | (131.8M) | |
-117.6M | -128.6M | -198.6M | -169.1M | -130.6M | -153M | -200.6M | -198.5M | -154.7M | -170.1M | -112.8M | -85.4M | -87.4M | -95M | -98.9M | -112.3M | -132.4M | -145.4M | -138.1M | -130.5M | |
(140.3M) | (139.5M) | (207M) | (177.1M) | (58.6M) | (115.6M) | (212.6M) | (201.7M) | -49K | (42.7M) | (105M) | (68.4M) | (64.4M) | (63.3M) | (122.9M) | (109.9M) | (71M) | (71.8M) | (57.3M) | (46.7M) | |
-61.8M | -93.5M | -172.5M | -142.7M | -84.1M | -111.2M | -207.1M | -181.7M | -153.4M | -119.1M | -66.4M | -80.7M | -103.6M | -93.3M | -127M | -112.1M | -119.4M | -144.5M | -138.2M | -132M | |
272.7M | 174.8M | 382.4M | 260.6M | 629.7M | 456.5M | 264.7M | 235.6M | 202.5M | 180.7M | 208.4M | 203.8M | 197.8M | 243.6M | 183.7M | 124M | 116.4M | 51.9M | 54.1M | 125.9M | |
NET INCOME | ||||||||||||||||||||
(58.2M) | (44.8M) | (82.6M) | (62.6M) | (129.8M) | (111.9M) | (63.7M) | (58.6M) | -18.2M | (55.5M) | (72.4M) | (75.6M) | (74.8M) | (89.7M) | (71M) | (41.6M) | (37.5M) | (26.1M) | (18.7M) | (43.5M) | |
146.2M | 214M | 243.5M | 159M | 402.2M | 259M | 201M | 137.8M | 177.2M | 115.4M | 130.7M | 120.6M | 114.4M | 148.2M | 107.8M | 77.6M | 75.3M | 22.4M | 35.4M | 94.9M |
SEM - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | April 30, 2026 | April 28, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | April 30, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 24, 2026 | April 23, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | March 04, 2026 | April 23, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 03, 2026 | March 02, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 19, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 19, 2026 | February 12, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 19, 2025 | December 17, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 25, 2025 | November 24, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | October 30, 2025 | September 30, 2025 | 2025 |
Continue your SEM research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.